Open AccessAssociation of metabolic syndrome with glioblastoma: a retrospective cohort study and review
Author(s) -
Lisa Rogers,
Quinn T. Ostrom,
Julia Schröer,
Jaime Vengoechea,
Li Li,
Stanton L. Gerson,
Charles J. Nock,
Mitchell Machtay,
Warren R. Selman,
Simon S. Lo,
Andrew E. Sloan,
Jill S. BarnholtzSloan
Publication year - 2020
Publication title -
neuro-oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 14
eISSN - 2054-2585
pISSN - 2054-2577
DOI - 10.1093/nop/npaa011
Subject(s) - medicine , metabolic syndrome , temozolomide , retrospective cohort study , cohort , population , oncology , radiation therapy , obesity , environmental health
Metabolic syndrome is identified as a risk factor for the development of several systemic cancers, but its frequency among patients with glioblastoma and its association with clinical outcomes have yet to be determined. The aim of this study was to investigate metabolic syndrome as a risk factor for and affecting survival in glioblastoma patients.